Trial Profile
A Multicenter Phase II Evaluation of Targretin (Bexarotene) Capsules in Patients With Advanced Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2005
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 17 Sep 2005 New trial record.